AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Ohglip M 1mg/500mg Tablet

Prescription Icon
Prescription Required

Marketer

Orenburg Healthcare Pvt. Ltd.

Salt Composition

Glimepiride (1mg) + Metformin (500mg)

Overview Ohglip M 1mg/500mg Tablet

Glycipan MD 1mg/500mg tablets are classified as antidiabetic agents. This dual-action medication treats type 2 diabetes in adults by regulating blood glucose. Glycipan MD should be ingested with meals, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may be adjusted based on your blood sugar response. Continued use is crucial, even with controlled blood sugar, as abrupt cessation can lead to elevated glucose levels and potentially serious complications, including kidney impairment, vision loss, neuropathy, and limb amputation. This medication complements a comprehensive diabetes management plan including a balanced diet, regular physical activity, and weight management as recommended by your doctor. Lifestyle choices are vital to diabetes control. Hypoglycemia (low blood sugar) is a prevalent side effect, characterized by sweating, lightheadedness, headache, and tremors. Regular meals and readily available glucose sources (e.g., sugary snacks, fruit juice) are essential. Alcohol consumption should be minimized due to its potential to exacerbate hypoglycemia. Additional potential side effects include altered taste, nausea, diarrhea, abdominal discomfort, cephalalgia, and upper respiratory infections. Weight gain may occur. This medication is contraindicated in individuals with type 1 diabetes, diabetic ketoacidosis, or severe hepatic or renal impairment. Prior heart conditions should be disclosed to your doctor before initiating treatment. Pregnant or lactating individuals require medical consultation before use. Regular blood glucose monitoring, along with potential blood tests to evaluate blood cell counts and liver function, will be advised by your doctor.

Primary Ingredients of Ohglip M 1mg/500mg Tablet

No information provided. A rewrite is impossible.

Uses of Ohglip M 1mg/500mg Tablet

Managing type 2 diabetes

Major Benefits of Ohglip M 1mg/500mg Tablet:

Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. It is recommended to take Ohglip M 1mg/500mg Tablet with a meal.

Common Side effects of Ohglip M 1mg/500mg Tablet:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Ohglip M 1mg/500mg Tablet:

Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment schedule. Ingest the Ohglip M 1mg/500mg tablet whole; avoid chewing, crushing, or fracturing it. Administer this medication with a meal.

How Ohglip M 1mg/500mg Tablet works:

Ohglip M 1mg/500mg tablets contain glimepiride and metformin, two antidiabetic agents. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion to reduce blood sugar. Metformin, a biguanide, acts by decreasing hepatic glucose production, slowing intestinal glucose absorption, and enhancing insulin sensitivity.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Concurrent alcohol and Ohglip M 1mg/500mg Tablet ingestion is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

Using Ohglip M 1mg/500mg tablets during pregnancy may pose risks. While human research is scant, animal studies indicate potential harm to the fetus. A physician will assess the advantages against possible risks prior to prescription. Seek medical advice.

Breast feedingBreast feedingUNSAFE

Breastfeeding mothers should not take Ohglip M 1mg/500mg tablets. Evidence indicates potential infant harm from this medication.

DrivingDrivingCAUTION

Driving may be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these blood sugar imbalances.

KidneyKidneyCAUTION

Patients with impaired kidney function should use Ohglip M 1mg/500mg tablets cautiously, potentially requiring dosage modification under medical supervision. The medication is contraindicated in those with severely compromised kidney function. Close monitoring of renal function is recommended during treatment.

LiverLiverCAUTION

Individuals with liver impairment should use Ohglip M 1mg/500mg tablets cautiously, potentially requiring dosage modification. Medical advice is essential. For those with mild to moderate liver disease, a low starting dose is typically recommended; however, its use is contraindicated in patients with severe liver dysfunction.

What if you forget to take Ohglip M 1mg/500mg Tablet :

Should you forget to take your Ohglip M 1mg/500mg Tablet, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Ohglip M 1mg/500mg Tablet

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Ohglip M 1mg/500mg Tablet

Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Ohglip M 1mg/500mg Tablets can cause lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as MALA—Metformin-associated lactic acidosis). This rare but potentially harmful side effect is more likely in patients with kidney disease, older adults, or those who consume significant amounts of alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, discontinue Ohglip M 1mg/500mg Tablets and seek immediate medical attention.
Ohglip M 1mg/500mg tablets combine glimepiride and metformin to manage type 2 diabetes mellitus in adults. This combination improves blood glucose control when used with diet and exercise. Glimepiride stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. Ohglip M is not suitable for type 1 diabetes.
Ohglip M 1mg/500mg tablets may cause common side effects such as low blood sugar (hypoglycemia), altered taste, nausea, stomach pain, diarrhea, and headache. Rare but serious side effects include lactic acidosis. Prolonged use can also result in vitamin B12 deficiency.
Prolonged Ohglip M 1mg/500mg Tablet use can lead to Vitamin B12 deficiency by impairing its absorption. This deficiency, if left untreated, may result in anemia, neurological issues such as tingling, numbness in extremities, weakness, urinary problems, cognitive changes, and ataxia. To mitigate this risk, annual supplementation with Vitamin B12 is recommended by some researchers.
Yes, Ohglip M 1mg/500mg Tablets can lower blood sugar (cause hypoglycemia). Symptoms include nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, and anxiety or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other diabetes medications. Therefore, regular blood sugar monitoring is crucial. Always carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice.
Combining Ohglip M 1mg/500mg tablets and alcohol is unsafe. Alcohol can exacerbate the drug's effect, potentially causing dangerously low blood sugar (hypoglycemia) and increasing the risk of lactic acidosis.
Ohglip M 1mg/500mg Tablet
85
MRP 98
13% off